Shares of Canfor Co. (TSE:CFP – Get Free Report) have received a consensus recommendation of “Hold” from the seven brokerages that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is C$18.67.
CFP has been the subject of a number of analyst reports. CIBC lowered shares of Canfor from an “outperform” rating to a “neutral” rating and cut their price objective for the company from C$19.00 to C$16.00 in a research report on Tuesday. TD Securities reduced their price target on Canfor from C$19.00 to C$17.00 and set a “buy” rating on the stock in a research note on Thursday, April 17th. Royal Bank of Canada dropped their target price on Canfor from C$19.00 to C$16.00 and set an “outperform” rating for the company in a research note on Tuesday. Cibc World Mkts downgraded Canfor from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Finally, Raymond James lowered their price target on Canfor from C$28.00 to C$24.00 in a report on Thursday, January 30th.
Check Out Our Latest Research Report on CFP
Canfor Trading Up 1.9 %
About Canfor
Canfor Corporation operates as an integrated forest products company in the United States, Asia, Canada, Europe, and internationally. It operates in two segments, Lumber, and Pulp and Paper. The company manufactures and sells softwood lumber, remanufactured lumber products, engineered wood, and other lumber-related products, as well as wood chips and pellets; and generates green energy.
See Also
- Five stocks we like better than Canfor
- Why Invest in 5G? How to Invest in 5G Stocks
- Short Sellers Gave Up on These 3 Names Recently
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Boring Stocks Outperforming the Market This Year
- What is a Secondary Public Offering? What Investors Need to Know
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for Canfor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canfor and related companies with MarketBeat.com's FREE daily email newsletter.